Placebo News and Research

RSS

Study sheds new light on the links between infections with inflammation and empathy for pain

When people are ill, they feel less empathy for others than when they are healthy. This has been confirmed by a study conducted by Ruhr University Bochum and the University of Duisburg-Essen, Germany.

8 May 2024

MS Australia urges government action on neurological research funding

MS Australia has welcomed the Government's pledge to invest in health and medical research but is concerned that not enough attention or funding is being dedicated to neurological research.

8 May 2024

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

6 May 2024

Study sheds light on the promising role of virtual reality in treating depression

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

6 May 2024

Plant-based medication may be an effective therapy to help people quit vaping

Eleven million U.S. adults use e-cigarettes to vape nicotine, and about half of them say that they want to stop, but many have trouble doing so because nicotine is an addictive drug.

6 May 2024

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency (EMA) seeking to expand the Marketing Authorization Application for TREMFYA® (guselkumab) to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

6 May 2024

Varenicline dosage increase helps persistent smokers quit

For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased.

3 May 2024

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.

2 May 2024

Psilocybin found to be more effective than controls for treating depression symptoms

Psilocybin - the active ingredient in "magic" mushrooms - is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published by The BMJ today.

1 May 2024

New monoclonal antibody vaccine slashes malaria risk in children

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and 77%, respectively.

30 Apr 2024

Psychedelic compound shows promise in stress relief for socially aggressive mice

A study in Neuropharmacology reveals that a single dose of the psychedelic compound (R)-DOI significantly improves stress-coping behaviors and reduces inflammatory markers in mice subjected to social aggression.

30 Apr 2024

Georgetown study raises concerns over aspirin's role in breast cancer treatment

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

29 Apr 2024

Placebo News and Research

Study sheds new light on the links between infections with inflammation and empathy for pain

MS Australia urges government action on neurological research funding

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

Study sheds light on the promising role of virtual reality in treating depression

Plant-based medication may be an effective therapy to help people quit vaping

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

Varenicline dosage increase helps persistent smokers quit

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Psilocybin found to be more effective than controls for treating depression symptoms

New monoclonal antibody vaccine slashes malaria risk in children

Psychedelic compound shows promise in stress relief for socially aggressive mice

Georgetown study raises concerns over aspirin's role in breast cancer treatment

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

Japanese researchers test cardiac spheroids for heart regeneration in monkeys

Exploring the potential of ketogenic diets in managing epilepsy

Advancing medical treatment with causal machine learning

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging

Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News